A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia

NCT06368414 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

69

Enrollment

NETWORK

Sponsor class

Conditions

Chronic Myeloid Leukemia, Chronic Phase

Interventions

DRUG: Asciminib

Sponsor

Korean Society of Hematology